Introduction: This study provided physicians with continuing medical education (CME)
INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a highly prevalent and serious chronic, debilitating disease. Extensive evidence exists for the benefit of maintaining tight glycemic control to reduce the risk for complications. Despite this evidence, many patients do not maintain tight glycemic control with one reason being clinical inertia [1] . Clinical inertia is the failure to intensify therapy despite suboptimal glycemic control. Implementation of educational programs that emphasize the importance of glycemic control and increase awareness of tools to achieve this control among primary care physicians may be an important factor in devising successful treatment regimens that result in improved outcomes [1] . The ultimate goal of continuing medical education (CME) is to transfer learned knowledge, competence, and performance related skills into the practice setting [2] . Improvements in patient health outcomes may indicate whether or not physician participation in CME activities was effective in modifying clinical practice patterns. Research evaluating CME effectiveness has indicated that multiple educational platforms and case-based studies are more successful than the traditional didactic sessions alone at improving patient health outcomes [3, 4] . Several key factors for improving T2DM management include realistic goal-setting related to glycated hemoglobin (Hb1Ac) levels, improved knowledge and understanding of pharmacotherapeutic treatment options, early detection of problems, and prompt clinical intervention [1] . One aim of this study was to provide physicians with education specific to insulin to implement changes in their delivery of care to patients with T2DM. To address this, a combined live didactic session and online case-based interactive diabetes CME curricula were developed. The effectiveness of the CME program on physician knowledge, competence, and performance outcomes was assessed [2] . In addition, the impact of the curricula on changes in physician behavior in the clinical practice was assessed by measuring patient health outcomes before and after the CME activities.
METHODS

Continuing Medical Education Curricula and Time Line
Multiple platform CME curricula were jointly Clinicians were offered participation in one or both of the online case studies based on scores they achieved following the live CME event.
The CME curricula were designed with the following learning objectives: 1. Apply current data from clinical trials for Physicians completed questionnaires for baseline visits occurring within 3 months prior to the attended live CME event. If a patient had more than one office visit during the 3-month baseline period, the most recent visit was used for the completion of the questionnaire. Physicians also completed a follow-up questionnaire for visits occurring within 6 months after the live CME event. If more than one visit occurred during the 6-month follow-up period, then the last visit during the 6-month period was used for the chart review, since the HbA1c measurement there represents the final HbA1c in the follow-up period. Institutional Review Board approval was not required, since patient identifiable information was not collected, and the observational data were used solely for quality improvement purposes.
Assessment of Physician Learner Performance and Patient Health Outcomes
Improvement in physician learner performance and patient health outcomes were evaluated based on Moore's framework outcome levels 1-6 [2] , which were evaluated through the following means:
• Pre-and post-activity surveys to measure baseline and immediate changes in declarative (level 3A) and procedural knowledge (level 3B)
• 30 to 60-day follow-up survey to measure impact on clinical decision making and changes in practice (levels 5)
• Patient chart review to measure impact on clinical decision making and the resultant patient health outcomes (levels 5 and 6)
Statistical Analysis
Data on physician learner performance, along with patient chart review data from the baseline and follow-up visit questionnaires, were entered into an Excel-based study report form. Patient health outcome study endpoints included mean reduction in HbA1c, percent of patients with an 
RESULTS
Summary of Physician Participation in CME Activities and Patient Chart Review
A total of 4112 primary care physicians attended 1 of 7 identical CME live programs on T2DM between February and December 2012 (Table 1) .
Of these, 445 replied with interest in the study, and 34 of 445 physicians completed both phases (live program and online case-based study) of the CME curricula. These physicians submitted 264 patient chart review forms (Table 1) . Table 1 lists a breakdown of the number of patient charts submitted per physician as well as the number of participating physicians from each live CME site.
Physician Learner Knowledge, Competence and Performance Scores
A summary of physician learner pre-and post-CME mean test scores for outcomes for the online version of the same presentation (Table 2) . Competence outcome scores were significantly higher post-CME for all sites except New York and Boston (Table 2 ).
Knowledge outcome scores significantly improved post-CME for all sites except New York (Table 2) . For the interactive case-based studies, knowledge significantly improved (p\0.0005) for most categories (Table 2) . Table 3 summarizes mean baseline characteristics captured in the patient chart reviews. Patient chart reviews were completed for 264 patients, of which 51.89% (n = 137) were male. The mean age of patients was 53.98 years (SD = 13.06). The mean duration of T2DM disease was 4.62 years. The mean HbA1c level at baseline was 9.37%
Patient Health Baseline Characteristics and Outcomes
(SD = 1.62%), and only 3.41% of patients (n = 9) had a baseline HbA1c level B7.0%.
Improvements in patient health outcomes
were observed in the follow-up period when comparing patient data captured in the follow-up chart reviews to the baseline patient data. The mean reduction in Hb1Ac levels and additional use of anti-diabetic medications were the primary endpoints measured for assessing patient health outcomes. Figure 1 illustrates a comparison of the mean Hb1Ac levels observed at the follow-up (8.22%; SD = 1.60%) and baseline (9.37%; SD = 1.62%) visits. A mean patient HbA1c absolute reduction of 1.15% (p\0.0001) was observed in the follow-up period (Fig. 1) . Table 4 lists additional endpoint results for patient health outcomes. 44.3% (n = 117) of patients initiated insulin therapy between the baseline and follow-up period. 64.4% percent (n = 170) of patients had a reduction in HbA1c levels of at least 0.5% (Table 4 ). 20.3% of patients (n = 50) had a mean HbA1c level B7.0% in the follow-up period compared to 3.41% of patients prior to the CME activities (baseline) (p\0.0001). In addition, therapy was intensified for 75% of patients (n = 197) in the follow-up period.
DISCUSSION
Data from this study suggest that there is a potentially positive relationship between physician participation in a multiple platform CME curriculum and improvements in the outcomes of patients with T2DM. Significant improvements (p\0.0005) in specific CME health outcomes, as measured by this study, were also observed. These patient health outcomes were designed to measure level 6 of Moore's framework [2] for assessing CME All scores presented as the mean % (SD) *p\0.05, **p\0.0005 CME continuing medical education, SD standard deviation program effectiveness, which evaluates the degree to which the health status of patients improves due to changes in the practice behavior of physicians [2] . This study used the reduction of mean HbA1C levels and additional use of anti-diabetic medication as the main endpoints for the evaluation of health outcomes; however, the management of diabetes may be multi-facet and may include other elements, such as patient satisfaction, etc., which were not evaluated in this study. Improved patient health outcomes included a significant reduction in mean HbA1c levels and BMI body mass index, HbA1c glycated hemoglobin, SD standard deviation Several risks of bias are present in the study design which may contribute to alternate explanations for the improvements in patient health outcomes. Primarily, it is unknown how physicians selected the patients to include in this study, and it is possible that patients who had the greatest improvements were selectively chosen.
However, the patient chart forms consisted of 25 questions with the main endpoint of Hb1Ac level embedded within these questions. In addition, physicians were blinded to the specific outcomes to be assessed. Therefore, deliberate selection of patients demonstrating improvements in Hb1Ac levels is not likely to have been a systematic method of patient selection. The response rate was low with only a small subset of physicians participating in the multiple CME curricula and completing patient chart reviews, and this could have skewed the results. This low rate of participation limits conclusions drawn on the impact of the CME on physician performance and improvements in patient health outcomes.
In addition, physicians that were more willing to participate in this quality improvement study may be more willing to change their practice versus those that did not participate. Improvements in patient health outcomes included a significant reduction in HbA1c levels, reduced barriers to the use of insulin, and reduced clinical inertia in patients with T2DM. These data suggest that CME which addresses physician knowledge gaps can potentially impact patient health outcomes.
Future studies are needed to establish a direct link between individual physician improvements and patient health outcomes post-CME activities.
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